Asensus Surgical Inc (ASXC) Stock Price, Forecast & Analysis
USA - NYSEARCA:ASXC - US04367G1031 - Common Stock
ASXC Key Statistics, Chart & Performance
The current stock price of ASXC is 0.3479 USD. In the past month the price increased by 2.9%. In the past year, price increased by 23.37%.
ASXC Latest News, Press Relases and Analysis
ASXC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.94 | 216.56B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.55 | 199.24B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.54B | ||
| SYK | STRYKER CORP | 27.47 | 138.29B | ||
| IDXX | IDEXX LABORATORIES INC | 55.34 | 55.83B | ||
| BDX | BECTON DICKINSON AND CO | 13.16 | 54.41B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.99 | 49.77B | ||
| RMD | RESMED INC | 24.62 | 35.57B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.15 | 33.84B | ||
| PODD | INSULET CORP | 69.54 | 22.37B | ||
| DXCM | DEXCOM INC | 31.51 | 22.98B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.07 | 17.74B |
Related stock screener links
About ASXC
Company Profile
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 207 full-time employees. The company operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. The company is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The company is also working to incorporate all of this in the LUNA Surgical System.
Company Info
Asensus Surgical Inc
1 Tw Alexander Drive, Suite 160
Durham NORTH CAROLINA 27703 US
CEO: Anthony Fernando
Employees: 207
Phone: 19197658400
Asensus Surgical Inc / ASXC FAQ
What does ASXC do?
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 207 full-time employees. The company operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. The company is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The company is also working to incorporate all of this in the LUNA Surgical System.
Can you provide the latest stock price for Asensus Surgical Inc?
The current stock price of ASXC is 0.3479 USD. The price increased by 0.64% in the last trading session.
Does Asensus Surgical Inc pay dividends?
ASXC does not pay a dividend.
What is the ChartMill rating of Asensus Surgical Inc stock?
ASXC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for ASXC stock?
7 analysts have analysed ASXC and the average price target is 0.36 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 0.3479.
Can you provide the market cap for Asensus Surgical Inc?
Asensus Surgical Inc (ASXC) has a market capitalization of 94.62M USD. This makes ASXC a Micro Cap stock.
ASXC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ASXC. When comparing the yearly performance of all stocks, ASXC is one of the better performing stocks in the market, outperforming 91.45% of all stocks.
ASXC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ASXC. While ASXC seems to be doing ok healthwise, there are quite some concerns on its profitability.
ASXC Financial Highlights
Over the last trailing twelve months ASXC reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 17.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -192.86% | ||
| ROE | -604.36% | ||
| Debt/Equity | 0 |
ASXC Forecast & Estimates
7 analysts have analysed ASXC and the average price target is 0.36 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 0.3479.
For the next year, analysts expect an EPS growth of 21.03% and a revenue growth 43.58% for ASXC